MassIVE MSV000097787

Partial Public

Benchmarking In-Cell Proteomics For Profiling Neuroblastoma Cell Differentiation And The Ubiquitin-Proteasome System

Description

The human neuroblastoma SH-SY5Y cell line is a widely utilized model for studying neurodegenerative diseases, owing to its ability to differentiate into cells with a neuron-like phenotype. However, a comprehensive understanding of the cellular and molecular mechanisms underpinning the SH-SY5Y cell differentiation and maturation is still lacking from a deep proteomics perspective. We systematically benchmarked an “in-cell proteomics” strategy against the SDS lysate-based processing method and showed superior performance in terms of simplicity, sensitivity and quantitation accuracy while requiring minimal inputs. Next, we employed the in-cell proteomics strategy to characterize SH-SY5Y cells at undifferentiated, partially and terminally differentiated states, respectively. Among over 9,000 proteins quantified in total, we were able to detect marker proteins in neuronal development and integrity, and observed increases in glutamatergic synapse-related proteins and proteins previously reported in mature neurons as well as in differentiated neuroblastoma cells. Lastly, we examined proteins involved in the ubiquitin-proteasome pathway and found stage-specific expression of E3 ubiquitin ligases, deubiquitinases and proteasome subunits, revealing an important role of protein homeostasis in neuroblastoma cell differentiation. In summary, our study presented the first benchmark dataset of neuroblast cells using an in-cell proteomics strategy, and demonstrated its great potential in cataloging neuronal function and disease. [doi:10.25345/C50R9MG83] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: SH-SY5Y neuroblastoma ; On-filter in-cell (OFIC) ; E4technology ; DatasetType:Proteomics ; In-cell proteomics

Contact

Principal Investigators:
(in alphabetical order)
Zhihao Zhuang, Dept. of Chemistry & Biochemistry, University of Delaware, USA
Submitting User: yayu

Publications

Moafian Z, Marino MJ, Yu Y, Zhuang Z.
Benchmarking In-Cell Proteomics for Profiling Neuroblastoma Cell Differentiation and the Ubiquitin-Proteasome System.
J Proteome Res. Epub 2025 Nov 17.

Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.